| Autor: |
Herouet-Guicheney C; Bayer CropScience SA, BP153, 355 rue Dostoïevski, 06130 Sophia Antipolis, France. corinne.herouet-guicheney@bayercropscience.com, Rouquié D, Freyssinet M, Currier T, Martone A, Zhou J, Bates EE, Ferullo JM, Hendrickx K, Rouan D |
| Jazyk: |
angličtina |
| Zdroj: |
Regulatory toxicology and pharmacology : RTP [Regul Toxicol Pharmacol] 2009 Jul; Vol. 54 (2), pp. 143-53. Date of Electronic Publication: 2009 Mar 20. |
| DOI: |
10.1016/j.yrtph.2009.03.005 |
| Abstrakt: |
Glyphosate tolerance can be conferred by decreasing the herbicide's ability to inhibit the enzyme 5-enol pyruvylshikimate-3-phosphate synthase, which is essential for the biosynthesis of aromatic amino acids in all plants, fungi, and bacteria. Glyphosate tolerance is based upon the expression of the double mutant 5-enol pyruvylshikimate-3-phosphate synthase (2mEPSPS) protein. The 2mEPSPS protein, with a lower binding affinity for glyphosate, is highly resistant to the inhibition by glyphosate and thus allows sufficient enzyme activity for the plants to grow in the presence of herbicides that contain glyphosate. Based on both a review of published literature and experimental studies, the potential safety concerns related to the transgenic 2mEPSPS protein were assessed. The safety evaluation supports that the expressed protein is innocuous. The 2mEPSPS enzyme does not possess any of the properties associated with known toxins or allergens, including a lack of amino acid sequence similarity to known toxins and allergens, a rapid degradation in simulated gastric and intestinal fluids, and no adverse effects in mice after intravenous or oral administration (at 10 or 2000 mg/kg body weight, respectively). In conclusion, there is a reasonable certainty of no harm resulting from the inclusion of the 2mEPSPS protein in human food or in animal feed. |
| Databáze: |
MEDLINE |
| Externí odkaz: |
|
Full Text from ScienceDirect